首页>投融资
Red Queen Therapeutics
A轮
Red Queen Therapeutics is a clinical-stage biotechnology company preparing rapid responses to current and emerging pathogens that threaten human health and life.
Our novel plug-and-play antiviral platform, based on stapled peptide decoys, can be rapidly deployed against pandemic and pandemic-potential viruses, as well as other viruses that cause recurring, untreated disease.
基本信息
-
公司全称Red Queen Therapeutics Inc
-
类型多功能抗病毒药物研发商
-
产业领域药品研发/制造、化学药
-
公司人数不明确
-
地址Cambridge, Massachusetts, United States
-
联系电话203-232-7865
-
邮箱
-
成立时间2021-01-01
投融资
-
2024-08-06A轮5500万美元Apple Tree Partners
相关投融资企业
A轮
Tasca Therapeuticstasca是一家私营生物技术公司,专注于发现和开发在癌症中很重要的自棕榈酰化靶蛋白的小分子抑制剂。该公司的主导项目CP-383是同类首创的候选药物,对多种癌症类型具有很好的临床前活性。
A轮
Ambrosia Biosciences Inc.是一家私营药物发现公司,开发口服小分子疗法治疗肥胖症和其他代谢紊乱。该公司的平台为体重管理和代谢健康提供非侵入性方法,与一些传统药物相比,使患者能够有效地管理自己的病情,副作用更少。
种子轮
RenaissThera is a pharmaceutical company focused on developing affordable and innovative therapies, particularly targeting high unmet medical needs in areas like cardio-metabolic disorders, oncology, and immunology. Additionally, Renaiss Thera utilizes generative AI to accelerate drug discovery and target identification.